A B S T R A C T Normal blood lymphocytes bearing complement receptors (CRL) were divided into two populations, one expressing both CR1 (C4b-C3b receptor) and CR2 (C3d receptor) and a second expressing only CR1. Nearly all of the population that expressed both CR1 and CR2 also bore membrane surface immunoglobulins (Ig) and Ia antigens. 
INTRODUCTION
In several previous studies of complement receptor lymphocytes (CRL)1 the dominant finding has been that these cells are heterogeneous in their expression of different types of membrane markers (1) (2) (3) (4) (5) . Whereas most laboratories were in agreement that the CRL had surface immunoglobulin (Ig) and Fc receptors (FcR), some CRL did not have detectable surface Ig (2, 4, 5) , and a minor proportion of CRL formed erythrocyte (E) rosettes (6) . Thus, there was some question as to whether complement (C) receptor expression was restricted to the bone marrow-derived lymphocyte (Bcell) lineage. Because in the past the only reliable criteria for the identification of human B cells was the demonstration of membrane Ig determinants, the whole question of Ig-CRL was revived when it was shown that the usual techniques for measurement of surface Ig could lead to an overestimation of the proportion of Ig-bearing cells because anti-Ig reagents occasionally bound to FcR+ Ig-cells (7) . Recently, human Ta antigens have been shown to be B-cellspecific markers of considerable utility (8) , and simultaneous analysis of Ig and Ia antigens has led to the demonstration of Ig-la' B cells (9, 10) . Thus, the possibility arose that CRL which lack demonstrable Ig could be B cells if they expressed Ia antigens. Finally, any complete characterization of the CRL population should include the distinction of CRL which express either one or the other of two distinct types of C receptors. Although the majority of CRL contain both types of C receptors, some normal peripheral blood lymphocytes express only CR, (C4b-C3b receptor), whereas some other normal tonsil lymphocytes express only CR2 (C3d receptor) (4, 5) .
The present study was instituted to analytically evaluate the surface markers of the CRL by utilizing a combination of all of these advances in methodology. Normal blood CRL were found to be heterogeneous in their content of CR1, CR2, surface Ig, Ia antigens, and FcR. The majority of CRL expressed B-cellspecific surface Ig and (or) Ia determinants, whereas lymphocyte antigens encoded by I-region genes; KLH, keyhole limpet hemocyanin; OVA, ovalbumin; TRITC, tetramethylrhodamine isothiocyanate. a small proportion of CRL lacked both Ig and la antigens; included among these were a minor proportion of CRL that formed E-rosettes.
METHODS
Isolatiotn of tmtoniontuclear cells and(c idenitificatiotn of lymphocytes. Mononuclear cell fractions wvere obtained by density centrifugation (400 g, for 45 mill at 20°C) from whole or dextran-sedimented, heparinized normal blood, at the density interface formed with d = 1.078 g/ml Ficoll-Hypaque (Ficoll, Pharmacia Fine Chemicals Inc., Piscataway, N. J., Hypaque, Winthrop Laboratories, New York) (11, 12) . After two washes with phosphate-buffered saline (PBS), the cells were resuspended in Hanks' balanced salt solution and incubated with 1.1 ,um latex particles for 1 h at 37°C (12) . After removal of free latex particles by three washes with warm PBS at 400 g for 10 min, the cells were resuspended in PBS that contained 1% bovine serum albumin and 0.2% NaN3 and examined for the extent of latex ingestion by phagocytic cells. For this purpose, air-drained cell smears were stained for peroxidase containing cells (13) , followed by staining with Wright-Giemsa. From 10 to 35% of mononuclear cells ingested latex and this included an average of 95% of the monocytes and granulocytes simultaneously identified by peroxidase and Wright-Giemsa staining. Thus, 97-99% of the latex ingestion-negative cells were lymphocytes.
Assay for CR1 arnd CR2-bearing cells. CR, and CR2 were detected as previously described by rosette formation with sheep erythrocyte-rabbit IgM antibody-complement complexes (EAC): EAC14b, EAC1-3b, and EACl-3d prepared with purified human C components (14) .
Preparation of fluorochrome-contjugated anti-Ig. Rabbit antisera specific for immunoglobulin ,u-, 8-, a-, and y-heavy chains and K-and X-light chains were prepared and appropriately absorbed oIn solid phase immunoabsorbants. After isolation of IgG antibody from each antiserum by DEAE cellulose chromatography (12) , each anti-Ig type was divided into two parts, one that was treated with pepsin (Worthington Biochemical Corp., Freehold, N. J.) to produce F(ab')2 fragments (15) , and the other that was retained as whole IgG. The minimum amount of pepsin required for complete cleavage of all IgG was separately determined with each antibody by pilot studies analyzed by electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. In some instances, the duration that the isolated IgG was stored before digestion and the particular preparation of pepsin necessitated adjustment of the time and concentration of pepsin used for digestion. F(ab')2 fragments were separated from trace amounts of uncleaved IgG and from pFc fragments by gel filtration on a 5 x 150-cm column of either Sephacryl S-200 or Sephadex G-150 (Pharmacia Fine Chemicals Inc.) equilibrated with 0.05 M Tris citrate buffer pH 8.0 that contained 1.0 M NaCl. The F(ab')2 fragments were shown to be free of uncleaved IgG and pFc fragments by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by immunodiffusion analysis with goat anti-rabbit Fc fragment specific serum. Any trace amounts of uncleaved IgG antibody were removed by absorption with Protein A-Sepharose (Pharmacia Fine Chemicals Inc.). Both the whole IgG and F(ab')2-anti-Ig were conjugated to tetramethylrhodamine isothiocyanate (TRITC), and conjugate fractions eluting from DE-52 Cellulose (Whatman, Inc., Clifton, N. J.) columns with 0.05-0.125 M NaCl in 0.01 M sodium phosphate pH 7.5 were used to stain cells (16, 17) . Each TRITC-anti-Ig conjugate was tested for both specificity and potency in fluorescence staining of lymphoid cell lines. Additional absorptions were made according to the analyses of the patterns of fluorescence staining obtained with either various established lymphoblastoid cell lines or chronic lymphatic leukemic lymphocytes known to containi only one particular heavy chain class and light chain type. In subsequent tests with normal lymphocytes, the anti-Ig reageint was used at a two to fourfold higher concentration than that which gave the maximumli number and fluorescence intensity of staine(d cells.
IlinImuInofluot-escetnce assay for surf(ace Ig, FcR, and(c 1( atntigetns. Direct immlluniofluorescenlce staining of surface Ig was performed with either the whole IgG or F(ab')2-anti-Ig TRITC con-jugate as previously described (12, 17) . FcR were detected by fluorescence assay with soluble fluorochromeconjugated immune complexes prepared at antibody excess (12, 18) . Ia antigens were fluorescence stained with a rabbit F(ab')2 anti-la-fluorescein isothicyanate (FITC) (or TRITC) conjugate, prepared and tested as described previously (9) . Spontaneous shleel) erythtrocyte rosettes (E-rosettes), thyniusderived lmnphocyte (T-cell)-en riche(l, ancd T-cell-depleted fractiotns. E rosettes were formed with either neuraminidasetreated sheep E (19) or with untreated E in the presence of heat-inactivated human AB serum at 4°C (20) . T-cell-enriched and T-cell-depleted fractions were prepared from monionuclear cell fractions by separation of E-rosettes on FicollHypaque gradients (20 Either FITC-sheep anti-IgA-IgA or rabbit anti-OVA-OVA immune complexes or a mixture ofthese two types of complexes was used to label FcR in combination with TRITC-F(ab')2-anti-la and EACl-3b for simultaneous assay of Ia antigens and CR1 (Table III) .
With anti-OVA-OVA complexes, the majority of cells labeled were la-CR1-(11.7%). Among the CR,+ cells, nearly all of the Ia-CR1+ cells were stained (3.2%), whereas only a small proportion of Ia+ CR1+ cells were stained (1.2%). Anti-IgA-IgA complexes differed from the anti-OVA-OVA complexes in that they predominantly labeled la+ CR1+ cells (13.4%) and bound to few la-CR1-cells (0.4%).
The heterogeneity of immune complex binding to different cell populations was further revealed when cells were simultaneously stained with the anti-IgA complexes plus the anti-OVA complexes (Table III) . FcR were detected on both Ia+ and la-CRL, and in addition, FcR were detected on 12% Ia-CR1-cells. Clearly, there were more than 28% FcR-bearing cells, the majority of which bound either one or the other of the two immune complexes examined.
Expression of CR1 ont Cells formting E rosettes. Because 3% of normal blood lymphocytes contained CR1 but lacked detectable B-cell-specific Ig and la de- (Table IV) . By contrast, only 2.1% CR,+ cells were detected in T-cell fractions, including 1.6% la-CR1+
cells. Even though B-cell fractions contained a much higher proportion of la-CR1+ cells than did T-cell fractions, the B-cell fractions represented only 18% of the unseparated lymphocytes, whereas the T-cell fractions contained the remaining 82% of lymphocytes. Thus, it could be calculated that whole blood contained 2.2% (18% of 12%) E-rosette-negative la-CR,+ cells and 1.3% (82% of 1.6%) of E-rosette-positive la-CR,+ cells. Parallel assay for EAC1-3d rosette formation in these same T-cell fractions revealed only 0.3% CR2-bearing cells, all of which contained Ia determinants (data not shown). Thus, the E-rosette marker was associated with only a minor proportion of CR,-bearing cells and was absent from CR2-bearing cells.
DISCUSSION
The expressioin of C receptors is a well-recognized property of B cells, but there have been several conflicting reports of C receptors also present on T cells (6) and noii-B cells active in antibody dependent cellular cytotoxicity (21, 22) . The present study was undertaken because of the advent of several improved methods for detection of meImbrane markers and the availability of Ia as a reliable B-cell marker on Ig-posi-tive and some Ig-negative lymphocytes. Although Bcell-specific surface Ig or Ia antigens were detected on the majority of CRL, a minor proportion of CRL lacked these markers and these included some CRL that apparently expressed the T-cell marker of E rosette formation. FcR were detected on all normal blood CRL, but qualitative differences in the FcR of Ia+ CRL vs. Ia-CRL were recognized by their preferential binding ofone or the other oftwo different immune complex systems. In the past, many different types of studies have been performed in an attempt to determine whether the CRL were members of either the B-or T-lymphocyte population (23, 24) . The first of such studies in mice demonstrated that the majority of CRL were killed by anti-Ig and C (23), whereas conversely the proportion of CRL was increased by treatment of lymphocytes with anti-thy-i and C (25) . Thus, the CRL were part of the Ig-bearing B-cell population but not the thy-i bearing T-cell population. Subsequent direct studies with human lymphocytes demonstrated surface Ig by immunofluorescence on cells forming EAC rosettes, and an absence of C receptors on T cells forming E-rosettes (1, 2). However, whereas initial studies with whole IgG anti-Ig reagents indicated that all human blood CRL contained membrane Ig, significant proportions of Ig-CRL were also observed with these same reagents in both tonsils and spleen (2, 5) . This apparent inconsistency was a stimulus to the present study, especially with the advent of more reliable methods for detecting surface Ig and because of the availability of surface Ia as an additional B-cell marker.
A variety of different observations on the selective expression of human Ia determinants has made it increasingly evident that Ia is a more reliable marker of cells in the B-lymphocyte lineage than is surface Ig. Among normal lymphoid cells, nearly all Ig-bearing cells and plasma-cell precursors express Ia, whereas Ta is undetectable on the vast majority of non-B and T lymphocytes (9, 10, 26) . Furthermore, supporting evidence for Ia expression on Ig-negative pre-B cells has been provided by the demonstration of such characteristic pre-B cells in both normal marrow and marrow from patients with infantile hypogammaglobulinemia (27) . Similarly, the essential absence of such Ia+ Ig-cells in the blood from patients with infantile agammaglobulinemia supports the current concept that this disease results from a lesion in the developmental pathway of early B cells (10 (28) .
The present studies illustrated the differences between whole IgG anti-Ig and F(ab')2 anti-Ig reagents that were derived from the same antisera and demonstrated to have the same specificity and potency. This difference was still apparent after a i-h incubation and three washes in 37°C buffer, suggesting that small quantities of plasma Ig may still have been present. Moreover, these experiments demonstrate that a considerable proportion ofthe cells labeled with the whole IgG-anti-Ig reagent were not labeled with the F(ab')2 anti-Ig derivative and lacked C receptors entirely. These presumably represent the T cells with FcR previously identified as cells that secondarily bind the fluorescent reagent in complexed form (7) . Even though in most normal individuals there was little difference in the proportion of positive cells detected with whole IgG anti-,, 8 vs. F(ab')2 anti-,u, 8, it was also found, in some occasional individuals, that whole IgG-anti-,u, 8 stained 10-50% more lymphocytes than did its F(ab')2 derivative. Thus, for detection of membrane IgM and IgD, as well as IgG, it is preferable to use F(ab')2 rather than whole IgG antibodies.
Tests with mixtures ofEAC types confirmed previous findings (2, 5 ) that CR2-bearing cells (9.7% of lymphocytes) were a subpopulation of CR,-bearing cells (17.0% oflymphocytes). All normal blood CRL could be detected by rosette formation with either EAC14b or EACi-3b but not with EACi-3d. Nearly all cells bearing both CR1 and CR2 expressed Ig, whereas more than 5% of normal blood lymphocytes expressed CR1 but not CR2 and these lacked detectable membrane Ig. However, the CR2 assay does not detect all normal B cells, because an average of 2% of lymphocytes expressed surface Ig and lacked CR2.
To exclude the possibility that some Ig-CRL might be nonlymphoid cells, EAC-rosetted cells were simultaneously examined for latex ingestion, peroxidase staining, and Wright-Giemsa morphology. Nonlymphoid cells in lymphocyte preparations included monocytes (20%) and immature neutrophils (5%), all ofwhich were stained for peroxidase activity. More than 95% of peroxidase-positive cells ingested latex particles and thus were excluded from surface marker analysis. The remaining very minor proportion of peroxidase-positive latex-negative cells differed from Ig-CRL because most were CR,+ CR2', whereas Ig-CRL were CR,+ CR2-. Indeed, previous studies of monocytes (29) and imnmature neutrophils (30) (33, 34) . Table V summarizes the findings of this study. Five different CRL subsets were defined by the surface markers examined and these included 17% of peripheral blood lymphocytes. The first subset of CRL contained both CR1 and CR2, while the remaining four subsets contained only CR1. This first subset contains the majority of Ig+ CRL and would be the only subset detected if EAC1-3d were used to detect CRL. This is probably the explanation of the report that Ig-bearing cells and CRL were a completely overlapping homogeneous population of cells (35) , especially in view of the use of EAC prepared with whole mouse serum as a source of C and thus EAC1-3d (4), a preparation that is known to detect primarily only CR2 and fewer normal blood CRL than does an EAC1-3b preparation that detects CR1 (2, 4) . The first three CRL subsets are B cells because of their content of surface Ia determinants (8) (9) (10) . These three B-cell CRL subsets may reflect different stages of lymphocyte differentiation, rather than functionally different cell types. CR1, CR2, and FcR have been shown to be expressed sequentially during the process of granulocyte differentiation from immature bone marrow cells (30, 36) , and studies of mouse B lymphocytes have demonstrated a sequential appearance of C receptors during B-cell maturation (37) . The fourth and fifth CRL subset of Table V lacked both Ig and Ia determinants. The fifth subset, representing 1.1% of blood lymphocytes, not only lacked both Ig and Ia, but also formed E rosettes, a T-cell marker. However, these cells may not be T cells as there is an alternate possibility that they may be the CR1-bearing cells that mediate antibody-dependent cellular cytotoxicity (23, 38) . Final classification of the fourth and fifth CRL subsets will require their isolation and function analysis.
